Draft - work in progress
-
- Opuntia cylindrica (Lam.) DC
Opuntia cylindrica (Lam.) DC
- Family:
- Cactaceae
- Approval state:
- Approved
- Number of articles retrieved:
- 10
- Number of processed references:
- 3
Composition #1: Marini-Bettolo, G. B., Coch Frugoni, J. A. The influence of pH on the electrophoretic separation of alkaloids on paper. Rendiconti Istituto Superiore di Sanita (Italian Edition), 1958, p. 319–327. .
-
-
Substance:
mescaline (RF-00003925-PAR)
-
Yes/No Qualitative:
Positive/Present (POS)
-
Result type:
Qualitative Value (Binary) (BIN)
Composition #2: Turner, Wm. J., Heyman, Jack J. Presence of mescaline in Opuntia cylindrica. Journal of Organic Chemistry, 1960, p. 2250–2251. .
-
-
Plant part:
Live plants (as part-nature) (A0BA0)
-
Extraction/Preparation method:
Solvent extraction (A0BZR)
-
Additional extraction description:
methanol/aqueous ammonia
-
Substance:
mescaline (RF-00003925-PAR)
-
Analytical method code:
Chromatographic tests (F015A)
-
Result unit:
Percent (G138A)
-
Result expression:
Dry matter (B002A)
-
Result type:
Numerical Value (VAL)
-
Value (concentration, content):
0.9
-
Internal remarks:
mescaline
Endpoint study
#1: Buscaino, V. M. Experimental psychiatry. Excerpta Medica, Section 2: Physiology, Biochemistry and Pharmacology, 1950 . .
-
Study relevance:
Human health
-
Substance:
bulbocapnine (RF-00003719-PAR)
-
Type of toxicological test:
not reported (CHD015TT)
-
Endpoint measured:
Dose not reported (CHD066EP)
-
Critical effect:
NEUROTOXICITY (TOX04A)
-
Target tissue:
neurologic: Central Nervous System (TT035A)
-
Effect description:
catatonic effects
-
Effect or parameter linked to the endpoint:
neurology (CHD027BE)
-
Internal remarks:
catatonic effects
Endpoint study
#2: Buscaino, V. M. Experimental psychiatry. Excerpta Medica, Section 2: Physiology, Biochemistry and Pharmacology, 1950 . .
-
Study relevance:
Human health
-
Substance:
mescaline (RF-00003925-PAR)
-
Type of toxicological test:
not reported (CHD015TT)
-
Endpoint measured:
Dose not reported (CHD066EP)
-
Critical effect:
NEUROTOXICITY (TOX04A)
-
Target tissue:
neurologic: Central Nervous System (TT035A)
-
Effect description:
syndromes resembling schizophrenia
-
Effect or parameter linked to the endpoint:
neurology (CHD027BE)
-
Internal remarks:
mescaline - syndromes resembling schizophrenia
Endpoint study
#3: Buscaino, V. M. Experimental psychiatry. Excerpta Medica, Section 2: Physiology, Biochemistry and Pharmacology, 1950 . .
-
Study relevance:
Human health
-
Substance:
Lysergide (RF-00011010-PAR)
-
Type of toxicological test:
not reported (CHD015TT)
-
Endpoint measured:
Dose not reported (CHD066EP)
-
Critical effect:
NEUROTOXICITY (TOX04A)
-
Target tissue:
neurologic: Central Nervous System (TT035A)
-
Effect description:
syndromes resembling schizophrenia
-
Effect or parameter linked to the endpoint:
neurology (CHD027BE)
-
Internal remarks:
diethyllysergamide - syndromes resembling schizophrenia
